$1.29
-0.03 (-2.27%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+118.6% upside
Low Target
$1.78
Average Target
$2.82
High Target
$3.37
Current Price
$1.29
Current
$1.29
$1.29
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Scenario Analysis
Bear Case
$1.78
38.0%
Low target
Base Case
$2.82
+118.6%
Avg target
Bull Case
$3.37
+161.2%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$2.99
-56.9% from high
52-Week Low
$0.87
+48.0% from low
Target vs 52W High
$2.82
-5.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.2% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.7% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.6% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.8% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.2% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.5% |